NCT02986191

The Use of Mucograft® to Treat Gingival Recession

Clinical Applications of 3D Collagen Matrix (Mucograft®) in the Management of Gingival Recession: a Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Damascus University · Academic / Other
• Sex: All
• Age: 20 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

Twenty patients with gingival recession will be enrolled in this trial. Gingival recession will be treated in one side by applying Mucograft® with coronally advanced flap (CAF) while on the opposite side a connective tissue graft (from the palate) will be applied with a CAF. Patients will be followed for 3 and 6 months by measuring the clinical indexes and statistical analyses will be performed to compare the results and to assess the success of Mucograft®.

Detailed description

Many surgical techniques have used to treat gingival recession such aas repositioned flaps, autologous soft tissue grafts (connective tissue graft or free gingival grafts) or allografts like acellular dermal which can be used as substitutes for palatal donor tissue. Mucograft® (3D collagen matrix) is also an allograft from porcine origin and is designed for soft tissue regeneration and considered the ideal solution to autogenous soft tissue grafts and it provides an ideal matrix for blood vessel and soft tissue ingrowth.

Conditions

• Gingival Recession

Interventions

Type	Name	Description
PROCEDURE	Mucograft	This method of grafting will be used to treat the gingival recession using coronally advanced flaps.
PROCEDURE	Connective Tissue Graft	This will be used in the traditional manner to correct gingival recession

Timeline

• Start date: 2016-08-01
• Primary completion: 2017-04-01
• Completion: 2017-12-20
• First posted: 2016-12-08
• Last updated: 2018-02-06

Locations

1 site across 1 country: Syria